+ All Categories
Home > Documents > Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson,...

Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson,...

Date post: 16-Dec-2015
Category:
Upload: britton-mcdowell
View: 221 times
Download: 4 times
Share this document with a friend
Popular Tags:
10
Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of Health Bethesda, MD
Transcript
Page 1: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

Ocular Manifestations

Stella K. Kim, M.D.MD Anderson Cancer CenterHouston, TX

Michael R. Robinson, M.D.National Eye InstituteNational Institutes of HealthBethesda, MD

Page 2: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

Ocular Chronic GVHD: Response Criteria

• Background: Staging/grading systems for ocular GVHD

• Current applications of chronic GVHD response criteria

– Subjective symptom scale

– Objective measure: Schirmer’s test

• Considerations for pediatric patients

Page 3: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

Cicatricial Conjunctivitis Grading (Robinson 2004)

More relevant to CHRONIC manifestations, though it can occur prior to day 100 transplantation, de novo or post-pseudomembrane conjunctivitis

All I m

ages Ar e C

opy righ t Pro t ec t ed

Page 4: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

Assessing Ocular GVHD: Ophthalmic Evaluation Required

• Conjunctival staging/grading systems

• Corneal and conjunctival stainings

• Others (ocular surface disease tools, biopsy, etc.)

Page 5: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

Chronic GVHD Activity Assessment: Ocular

• Symptom measurement: Main eye symptom reporting (severity rating 0–10)

• Objective measurement: Schirmer’s test (measurement of aqueous tear production—surrogate of lacrimal gland function)

Page 6: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

Main Eye Symptom

• “What is your main complaint with regard to your eyes?”

• “Please rate how severe is this eye symptom, between 0 (not at all severe) to 10 (most severe)”

What is your main complaint with regard to your eyes?

Please rate how severe is this eye symptom, between 0 (not at all severe) and 10 (most severe):

0 1 2 3 4 5 6 7 8 9 10

Page 7: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

Schirmer’s Test • Measurement of tear function (record mm of wetting for left and right

eye separately)– Without anesthetic: measures both reflex and basal tear function– With anesthetic: measures basal tear function– For evaluation of chronic GVHD response, Schirmer’s is obtained

without anesthesia.1

Photos Courtesy of Dr. M. Robinson1. Vitali, C., Bombardieri, S., Jonsson, R. et al (2002). Classification criteria for Sjogren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Annals of Rheumatologic Disease, 61, 554-558.

All I m

ages Ar e C

opy righ t Pro t ec t ed

Page 8: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

• Bend at the 0 mm line• Important to place the strip at the very corner of the

eye (avoids possible corneal abrasion)

All I m

ages Ar e C

opy righ t Pro t ec t ed

Page 9: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

• Have patient keep his/her eyes closed for 5 minutes.• No talking (or chewing/eating). • Schirmer’s score should be recorded as mm of

wetting for left and right eye separately.

All I m

ages Ar e C

opy righ t Pro t ec t ed

Page 10: Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.

Schirmer’s Test

• Results may be influenced by other factors (e.g., medications and hydration level).

• Recommendation based on consensus is to defer Schirmer’s testing for patients less than 9 years old.

• Evaluation by an ophthalmologist may be needed for objective scoring in younger children.


Recommended